European Institute of Science AB

Equities

EURI B

SE0020357457

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-05-27 pm EDT			5-day change	1st Jan Change
3.7 ^SEK	-7.04%		-7.50%	-70.82%

Apr. 30	European Institute of Science AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Jan. 31	European Institute of Science AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

European Institute of Science AB Reports Earnings Results for the First Quarter Ended March 31, 2021

May 12, 2021 at 07:01 am EDT

European Institute of Science AB announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was SEK 115,000 compared to SEK 114,000 a year ago. Operating loss was SEK 634,000 compared to SEK 602,000 a year ago. Net loss was SEK 634,000 compared to SEK 602,000 a year ago.

Latest news about European Institute of Science AB

European Institute of Science AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30	CI
European Institute of Science AB Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 31	CI
European Institute of Science AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-31	CI
European Institute of Science AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-31	CI
European Institute of Science AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
European Institute of Science AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-01-31	CI
European Institute of Science AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-31	CI
European Institute of Science AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-24	CI
European Institute of Science AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-13	CI
European Institute of Science AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-30	CI
European Institute of Science AB Reports Earnings Results for the Full Year Ended December 31, 2021	22-01-31	CI
European Institute of Science AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-01-31	CI
European Institute of Science AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-28	CI
European Institute of Science AB Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-07-30	CI
European Institute of Science AB Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-12	CI
European Institute of Science AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-01-29	CI
European Institute of Science AB Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-30	CI
European Institute of Science AB Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-08	CI
European Institute of Science AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2019	20-01-31	CI
Norwegian Invest AB acquired an additional 8.1% stake in European Institute of Science AB (OM:EURI B).	14-10-15	CI

Chart European Institute of Science AB

Duration

Period

More charts

Company Profile

European Institute of Science AB (EURIS) is a Sweden-based commercial research center. The Company, through its wholly owned subsidiary, ScienceHouse Lund AB is engaged in the research, development, manufacturing, sales and marketing of medical technology, health care, cosmetics and personal care, biotechnology, energy, education and entertainment products and methods. Additionally, it is engaged in the investment in high-technology companies, as well as in leasing and management of properties. As of December 31, 2011, the Companyâs investments and project royalties included LifeAssays AB (publ), Biotech-IgG AB and Implementa Hebe AB (publ). The Companyâs products include liquid chromatography equipment for affinity purification of proteins and antibodies, and a range of products obtained from pooled human or animal plasma.

Sector

Biotechnology & Medical Research

Calendar

2024-08-19 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
EUROPEAN INSTITUTE OF SCIENCE AB	-70.82%	122K
MODERNA, INC.	+54.05%	58.71B
IQVIA HOLDINGS INC.	-2.02%	41.31B
LONZA GROUP AG	+40.01%	39.2B
CELLTRION, INC.	-10.22%	27.4B
ICON PUBLIC LIMITED COMPANY	+13.42%	26.55B
ALNYLAM PHARMACEUTICALS, INC.	-21.60%	18.98B
BIO-TECHNE CORPORATION	+2.89%	12.51B
UNITED THERAPEUTICS CORPORATION	+22.40%	11.94B
MEDPACE HOLDINGS, INC.	+27.49%	12.08B

Other Biotechnology & Medical Research